サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451782

植え込み型ドラッグデリバリーデバイス市場レポート：製品タイプ、技術、用途、エンドユーザー、地域別、2024-2032

Implantable Drug Delivery Devices Market Report by Product Type, Technology, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
植え込み型ドラッグデリバリーデバイス市場レポート：製品タイプ、技術、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

植え込み型ドラッグデリバリーデバイスの世界市場規模は2023年に143億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに263億米ドルに達し、2024～2032年の成長率（CAGR）は6.81%になると予測しています。慢性疾患の有病率の増加、低侵襲手術に対する需要の高まり、慢性疾患に罹患しやすい高齢者人口の増加、植え込み型デバイスの急速な技術進歩などが市場を牽引する主な要因です。

植え込み型ドラッグデリバリーデバイスは、体内に埋め込むことで、長期間にわたって薬物を持続的に放出することができます。これらのデバイスの構造には、リザーバーまたは薬物含有コンパートメント、放出メカニズム、薬物レベルまたは生理学的パラメータをモニターし、リアルタイムでフィードバックを提供するセンサーなど、いくつかの主要コンポーネントが含まれます。植え込み型ドラッグデリバリーデバイスは、血流中の薬物濃度を一定に保ち、経口薬に伴うピークや谷を避けることができるなど、従来の薬物投与法に比べて多くの利点を提供します。これにより、最適な治療レベルが確保され、患者のコンプライアンスも向上します。さらに、これらのデバイスは特定の間隔で薬物を放出するようにプログラムできるため、頻繁な投与の必要性が減り、患者の利便性が向上します。さらに、植え込み型ドラッグデリバリーデバイスは局所的な薬物送達を可能にするため、全身的な副作用を最小限に抑え、治療効果を高めることができます。現在、さまざまなタイプの植え込み型ドラッグデリバリーデバイスが利用可能であり、その中には、モーター駆動機構を利用してリザーバーから薬剤を制御された速度で押し出す埋め込み型ポンプも含まれます。

植え込み型ドラッグデリバリーデバイスの市場動向：

世界の植え込み型ドラッグデリバリーデバイス市場は、主にがん、糖尿病、心血管障害などの慢性疾患の有病率の上昇など、さまざまな要因によって加速しています。さらに、低侵襲手術に対する需要の高まりや、慢性疾患にかかりやすい高齢者人口の増加が、市場成長の原動力となっています。さらに、生分解性やプログラム可能なドラッグデリバリーシステムの開発など、埋め込み型デバイスの急速な技術進歩や、長期的な治療ソリューションに対する需要の高まりが、市場の成長を後押ししています。これに加えて、ヘルスケアコストの削減ニーズの高まりと、有利な償還政策の利用可能性が市場の成長を後押ししています。これに伴い、各国政府は先進ヘルスケア技術を促進するためのイニシアチブをとっており、これが市場成長を後押ししています。また、斬新で革新的な植え込み型ドラッグデリバリーデバイスの導入を目指した研究開発（R&D）活動の活発化も、市場拡大を後押ししています。このほか、植え込み型ドラッグデリバリーデバイスの利点に対する意識の高まりや、個別化医療や標的薬物送達への注目の高まりなども、市場拡大に寄与しています。

本レポートで扱う主な質問

  • 植え込み型ドラッグデリバリーデバイスの世界市場はこれまでどのように推移してきたか？
  • 植え込み型ドラッグデリバリーデバイスの世界市場における促進要因、抑制要因、機会は何か？
  • 各駆動要因、抑制要因、機会が植え込み型ドラッグデリバリーデバイスの世界市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的な植え込み型ドラッグデリバリーデバイス市場を代表する国は？
  • 製品タイプ別の市場内訳は？
  • 植え込み型ドラッグデリバリーデバイス市場で最も魅力的な製品タイプは？
  • 技術別の市場内訳は？
  • 植え込み型ドラッグデリバリーデバイス市場で最も魅力的な技術は？
  • 用途別の市場内訳は？
  • 植え込み型ドラッグデリバリーデバイス市場で最も魅力的な用途は？
  • エンドユーザー別の市場内訳は？
  • 植え込み型ドラッグデリバリーデバイス市場で最も魅力的なエンドユーザーは？
  • 世界の植え込み型ドラッグデリバリーデバイス市場の競争構造は？
  • 植え込み型ドラッグデリバリーデバイスの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 植え込み型ドラッグデリバリーデバイスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 植込み型薬剤溶出ステント
    • 市場動向
    • 市場予測
  • 埋め込み型避妊用ドラッグデリバリーデバイス
    • 市場動向
    • 市場予測
  • 埋め込み型眼内ドラッグデリバリーデバイス
    • 市場動向
    • 市場予測
  • 植込み型ブラキセラピーシードデバイス
    • 市場動向
    • 市場予測
  • 植え込み型ドラッグデリバリーポンプデバイス
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • 生分解性インプラント
    • 市場動向
    • 市場予測
  • 非生分解性インプラント
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • オンコロジー
    • 市場動向
    • 市場予測
  • 循環器
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • 産科と婦人科
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Delpor Inc.
    • Koninklijke DSM N.V.
    • Medtronic plc
    • Theragenics Corporation
図表

List of Figures

  • Figure 1: Global: Implantable Drug Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Implantable Drug Delivery Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Implantable Drug Delivery Devices Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Implantable Drug Delivery Devices Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Implantable Drug Delivery Devices Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Implantable Drug Delivery Devices Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Implantable Drug Delivery Devices Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Implantable Drug Delivery Devices (Implantable Drug Eluting Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Implantable Drug Delivery Devices (Implantable Drug Eluting Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Implantable Drug Delivery Devices (Implantable Contraceptive Drug Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Implantable Drug Delivery Devices (Implantable Contraceptive Drug Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Implantable Drug Delivery Devices (Implantable Intraocular Drug Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Implantable Drug Delivery Devices (Implantable Intraocular Drug Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Implantable Drug Delivery Devices (Implantable Brachytherapy Seeds Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Implantable Drug Delivery Devices (Implantable Brachytherapy Seeds Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Implantable Drug Delivery Devices (Implantable Drug Delivery Pump Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Implantable Drug Delivery Devices (Implantable Drug Delivery Pump Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Implantable Drug Delivery Devices (Biodegradable Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Implantable Drug Delivery Devices (Biodegradable Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Implantable Drug Delivery Devices (Non-Biodegradable Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Implantable Drug Delivery Devices (Non-Biodegradable Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Implantable Drug Delivery Devices (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Implantable Drug Delivery Devices (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Implantable Drug Delivery Devices (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Implantable Drug Delivery Devices (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Implantable Drug Delivery Devices (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Implantable Drug Delivery Devices (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Implantable Drug Delivery Devices (Obstetrics and Gynecology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Implantable Drug Delivery Devices (Obstetrics and Gynecology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Implantable Drug Delivery Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Implantable Drug Delivery Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Implantable Drug Delivery Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Implantable Drug Delivery Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Implantable Drug Delivery Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Implantable Drug Delivery Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Implantable Drug Delivery Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Implantable Drug Delivery Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Implantable Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Implantable Drug Delivery Devices Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Implantable Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Implantable Drug Delivery Devices Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Implantable Drug Delivery Devices Industry: Value Chain Analysis
  • Figure 90: Global: Implantable Drug Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Implantable Drug Delivery Devices Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Implantable Drug Delivery Devices Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Implantable Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Implantable Drug Delivery Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Implantable Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Implantable Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Implantable Drug Delivery Devices Market: Competitive Structure
  • Table 8: Global: Implantable Drug Delivery Devices Market: Key Players
目次
Product Code: SR112024A8302

The global implantable drug delivery devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.81% during 2024-2032. The increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, the growing geriatric population susceptible to chronic disorders, and rapid technological advancements in implantable devices are some of the key factors driving the market.

Implantable drug delivery devices are implanted within the body to enable the sustained release of drugs over an extended period. The construction of these devices involves several key components, including a reservoir or a drug-containing compartment, a release mechanism, and sensors to monitor drug levels or physiological parameters, providing real-time feedback. Implantable drug delivery devices offer numerous advantages over conventional drug administration methods, such as maintaining a constant drug concentration in the bloodstream and avoiding the peaks and troughs associated with oral medications. This ensures optimal therapeutic levels and improves patient compliance. Furthermore, these devices can be programmed to release drugs at specific intervals, reducing the need for frequent dosing and improving convenience for patients. Additionally, implantable drug delivery devices enable localized drug delivery, minimizing systemic side effects and enhancing the efficacy of treatment. Currently, there are various types of implantable drug delivery devices available, including implantable pump, which utilizes a motor-driven mechanism to push the drug out of the reservoir at a controlled rate.

Implantable Drug Delivery Devices Market Trends:

The global implantable drug delivery devices market is primarily accelerated by various factors, including the escalating prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Moreover, the rising demand for minimally invasive procedures and the growing geriatric population, which is more susceptible to chronic illnesses, are driving the market growth. Additionally, rapid technological advancements in implantable devices, such as the development of biodegradable and programmable drug delivery systems, and the escalating demand for long-term therapeutic solutions are fueling the market growth. Besides this, the escalating need to reduce healthcare costs and the availability of favorable reimbursement policies are bolstering the market growth. In line with this, governments of various nations are undertaking initiatives to promote advanced healthcare technologies, which, in turn, is propelling the market growth. The burgeoning research and development (R&D) activities aimed at introducing novel and innovative implantable drug delivery devices are also driving market expansion. Other factors, such as the growing awareness about the benefits of implantable drug delivery devices and enhancing focus on personalized medicine and targeted drug delivery, are contributing to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global implantable drug delivery devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, technology, application, and end user.

Product Type Insights:

Implantable Drug Eluting Stents

Implantable Contraceptive Drug Delivery Devices

Implantable Intraocular Drug Delivery Devices

Implantable Brachytherapy Seeds Devices

Implantable Drug Delivery Pump Devices

The report has provided a detailed breakup and analysis of the implantable drug delivery devices market based on the product type. This includes implantable drug eluting stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices. According to the report, implantable drug eluting stents represented the largest segment.

Technology Insights:

Biodegradable Implants

Non-Biodegradable Implants

A detailed breakup and analysis of the implantable drug delivery devices market based on technology has also been provided in the report. This includes biodegradable and non-biodegradable implants. According to the report, non-biodegradable implants accounted for the largest market share.

Application Insights:

Oncology

Cardiovascular

Autoimmune Diseases

Obstetrics and Gynecology

Others

The report has provided a detailed breakup and analysis of the implantable drug delivery devices market based on the application. This includes oncology, cardiovascular, autoimmune diseases, obstetrics and gynecology, and others. According to the report, cardiovascular represented the largest segment.

End User Insights:

Hospitals

Ambulatory Surgery Centers

Others

A detailed breakup and analysis of the implantable drug delivery devices market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for implantable drug delivery devices. Some of the factors driving the North America implantable drug delivery devices market included the expanding pharmaceutical industry, the emergence of new drug delivery techniques, the availability of skilled healthcare professionals, and the establishment of specialized clinics and hospitals.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global implantable drug delivery devices market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Delpor Inc., Koninklijke DSM N.V., Medtronic plc, Theragenics Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global implantable drug delivery devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global implantable drug delivery devices market?
  • What is the impact of each driver, restraint, and opportunity on the global implantable drug delivery devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive implantable drug delivery devices market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the implantable drug delivery devices market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the implantable drug delivery devices market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the implantable drug delivery devices market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the implantable drug delivery devices market?
  • What is the competitive structure of the global implantable drug delivery devices market?
  • Who are the key players/companies in the global implantable drug delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Implantable Drug Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Implantable Drug Eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Implantable Contraceptive Drug Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Implantable Intraocular Drug Delivery Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Implantable Brachytherapy Seeds Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Implantable Drug Delivery Pump Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biodegradable Implants
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Biodegradable Implants
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiovascular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoimmune Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Obstetrics and Gynecology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgery Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Delpor Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Koninklijke DSM N.V.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Medtronic plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Theragenics Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.